pillbase.ru

VIVJOA

Active substance: oteseconazole

CAPSULE · OTESECONAZOLE 150 mg/1

United StatesActive

Marketing holder: Mycovia Pharmaceuticals, Inc.

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
EU 1
  • Vivjoa
    oteseconazole
    EMEA/H/C/005682
    Gedeon Richter Plc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-c0d4-7808-8739-837b5bfc9766;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
74695-823
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 74695-823 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 74695-823 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 74695-823 · Verified 2026-10-09 · open in source